微创妇科手术临床试验中的种族和民族差异
这项横断面研究分析了2012至2023年高影响力期刊上发表的微创妇科手术随机对照试验,发现352项试验中仅65项(18.5%)报告了种族和/或民族数据,46项美国试验共4645名参与者中白人和黑人或非裔美国人参与者比例高于预期,而西班牙裔、亚裔、夏威夷原住民或其他太平洋岛民、印第安人或阿拉斯加原住民比例低于预期。
要点
- 352项微创妇科手术随机对照试验中仅18.5%报告种族和/或民族数据。
- 美国46项试验中白人参与者占比70.8% vs 预期59.6%(入组比1.66,95%CI 1.52-1.81)。
- 西班牙裔、亚裔等少数族裔参与者比例显著低于预期。
核心结论
- 在美国进行的微创妇科手术随机对照试验中,白人和黑人或非裔美国人参与者相较于其他种族比例过高,且不到五分之一的试验对民族进行了特征描述。
- 应努力改善未来微创妇科手术随机对照试验中的种族和民族招募公平性及报告。
研究设计与样本
- 横断面研究,在线审查2012年至2023年高影响力期刊上所有已发表的微创妇科手术随机对照试验。
- 共识别352项随机对照试验,其中65项(18.5%)有种族和/或民族数据。
- 分析其中46项源自美国的试验,共4645名参与者。
- 期刊包括所有第一四分位妇产科期刊,以及《新英格兰医学杂志》、《柳叶刀》、《英国医学杂志》和《美国医学会杂志》。
主要发现
- 65项有数据的试验中仅8项(17.4%)在种族之外还报告了民族。
- 白人参与者占比70.8% vs 预期59.6%(入组比1.66;95%CI 1.52-1.81)。
- 黑人或非裔美国人参与者占比15.4% vs 预期13.7%(入组比1.15;95%CI 1.03-1.29)。
- 西班牙裔参与者占比6.7% vs 预期19.0%(入组比0.31;95%CI 0.27-0.35),亚裔占比1.7% vs 预期6.1%(入组比0.26;95%CI 0.20-0.34)。
- 夏威夷原住民或其他太平洋岛民占比0.1% vs 预期0.3%(入组比0.21;95%CI 0.06-0.74),印第安人或阿拉斯加原住民占比0.2% vs 预期1.3%(入组比0.16;95%CI 0.08-0.32)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: To study racial and ethnic disparities in randomized controlled trials (RCTs) in minimally invasive gynecologic surgery (MIGS). DESIGN: Cross-sectional study. SETTING: Online review of all published MIGS RCTs in high-impact journals from 2012 to 2023. PATIENTS: Journals included all first quartile obstetrics and gynecology journals, as well as The New England Journal of Medicine, The Lancet, The British Medical Journal, and The Journal of the American Medical Association. The National Institutes of Health's PubMed and the ClinicalTrials.gov websites were queried using the following search terms from the American Board of Obstetrics and Gynecology's certifying examination bulletin 2022 to obtain relevant trials: adenomyosis, adnexal surgery, abnormal uterine bleeding, cystectomy, endometriosis, fibroids, gynecology, hysterectomy, hysteroscopy, laparoscopy, leiomyoma, minimally invasive gynecology, myomectomy, ovarian cyst, and robotic surgery. INTERVENTIONS: The US Census Bureau data were used to estimate the expected number of participants. We calculated the enrollment ratio (ER) of actual to expected participants for US trials with available race and ethnicity data. MEASUREMENTS AND MAIN RESULTS: A total of 352 RCTs were identified. Of these, race and/or ethnicity data were available in 65 studies (18.5%). We analyzed the 46 studies that originated in the United States, with a total of 4645 participants. Of these RCTs, only 8 (17.4%) reported ethnicity in addition to race. When comparing published RCT data with expected proportions of participants, White participants were overrepresented (70.8% vs. 59.6%; ER, 1.66; 95% confidence interval [CI], 1.52-1.81), as well as Black or African American participants (15.4% vs. 13.7%; ER, 1.15; 95% CI, 1.03-1.29). Hispanic (6.7% vs. 19.0%; ER, 0.31; 95% CI, 0.27-0.35), Asian (1.7% vs. 6.1%; ER, 0.26; 95% CI, 0.20-0.34), Native Hawaiian or other Pacific Islander (0.1% vs. 0.3%; ER, 0.21; 95% CI, 0.06-0.74), and Indian or Alaska Native participants (0.2% vs. 1.3%; ER, 0.16; 95% CI, 0.08-0.32) were underrepresented. When comparing race/ethnicity proportions in the 20 states where the RCTs were conducted, Black or African American participants were underrepresented. CONCLUSION: In MIGS RCTs conducted in the United States, White and Black or African American participants are overrepresented compared with other races, and ethnicity is characterized in fewer than one-fifth of trials. Efforts should be made to improve racial and ethnic recruitment equity and reporting in future MIGS RCTs.
引用
- Sweterlitsch KM, Meyer R, Ohayon A, et al. Clinical Trial Racial and Ethnic Disparities in Minimally Invasive Gynecologic Surgery. J Minim Invasive Gynecol. 2024. PMID: 38325584. doi:10.1016/j.jmig.2024.01.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。